Moneycontrol PRO
HomeNewsOpinionGlenmark faces a tough choice in API unit stake sale

Glenmark faces a tough choice in API unit stake sale

The API subsidiary Glenmark Life Sciences (GLS) is trading at undemanding valuations and is yet to reach its full potential

June 16, 2023 / 09:55 IST
Glenmark Pharma is reportedly looking to sell stake in API subsidiary Glenmark Life Sciences
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts